Cellectar Biosciences, Inc. Fair Value of Assets Acquired
Cellectar Biosciences, Inc. (CLRB) reported Fair Value of Assets Acquired of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueOfAssetsAcquired · last filed 2014-05-14
- Cellectar Biosciences, Inc. fair value of assets acquired for the quarter ending 2014-03-31 was $0.00.
- Cellectar Biosciences, Inc. fair value of assets acquired for the quarter ending 2013-12-31 was $0.00.
- Cellectar Biosciences, Inc. fair value of assets acquired for the quarter ending 2013-09-30 was $0.00.
- Cellectar Biosciences, Inc. fair value of assets acquired for the quarter ending 2013-06-30 was $0.00.
- Cellectar Biosciences, Inc. fair value of assets acquired for fiscal 2013 was $0.00.
- Cellectar Biosciences, Inc. fair value of assets acquired for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- Cellectar Biosciences, Inc. fair value of assets acquired for fiscal 2011 was $78.41K.
| Period end | Fair Value of Assets Acquired 3 month | Fair Value of Assets Acquired 6 month | Fair Value of Assets Acquired 6 month as first filed | Fair Value of Assets Acquired 9 month | Fair Value of Assets Acquired 9 month as first filed | Fair Value of Assets Acquired 12 month | Fair Value of Assets Acquired 104 month | Fair Value of Assets Acquired 107 month | Fair Value of Assets Acquired 110 month | Fair Value of Assets Acquired 113 month | Fair Value of Assets Acquired 116 month | Fair Value of Assets Acquired 119 month | Fair Value of Assets Acquired 122 month | Fair Value of Assets Acquired 125 month | Fair Value of Assets Acquired 128 month | Fair Value of Assets Acquired 131 month | Fair Value of Assets Acquired 134 month | Fair Value of Assets Acquired 137 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $78.41K 10-Q · filed 2014-05-14 | |||||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-19 | $0.00 derived: sum of 2 quarters · filed 2014-03-19 | $0.00 derived: sum of 3 quarters · filed 2014-03-19 | $0.00 10-K · filed 2014-03-19 | $78.41K 10-K · filed 2014-03-19 | |||||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $0.00 derived: sum of 2 quarters · filed 2013-11-13 | $0.00 10-Q · filed 2013-11-13 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $78.41K 10-Q · filed 2013-11-13 | |||||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $0.00 10-Q · filed 2013-08-12 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $78.41K 10-Q · filed 2013-08-12 | |||||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $78.41K 10-Q · filed 2013-05-15 | |||||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-19 | $0.00 derived: sum of 2 quarters · filed 2014-03-19 | $0.00 derived: sum of 3 quarters · filed 2014-03-19 | $0.00 10-K · filed 2014-03-19 | $78.41K 10-K · filed 2013-03-28 | |||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $0.00 derived: sum of 2 quarters · filed 2013-11-13 | $0.00 10-Q · filed 2013-11-13 | -$1.00 derived: sum of 4 quarters · filed 2013-11-13 | $78.41K 10-Q · filed 2012-11-06 | |||||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $0.00 10-Q · filed 2013-08-12 | -$1.00 derived: sum of 3 quarters · filed 2013-08-12 | -$1.00 derived: sum of 4 quarters · filed 2013-08-12 | $78.41K 10-Q · filed 2012-08-09 | |||||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-15 | -$1.00 derived: sum of 2 quarters · filed 2013-05-15 | -$1.00 derived: sum of 3 quarters · filed 2013-05-15 | $78.41K 10-Q · filed 2012-05-04 | ||||||||||||||
| 2011-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$1.00 derived: sum of 2 quarters · filed 2013-03-28 | $78.41K 10-K · filed 2013-03-28 | $78.41K 10-K · filed 2012-03-09 | ||||||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $78.41K 10-Q · filed 2012-11-06 | $78.41K 10-Q · filed 2011-11-07 | $78.41K 10-Q · filed 2011-11-07 | ||||||||||||||
| 2011-06-30 | $78.41K 10-Q · filed 2012-08-09 | $984.06K 10-Q · filed 2011-08-12 | $984.06K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |